One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis

Abstract

SARS-CoV-2 infections in patients with CF are not as rare as initially anticipated, as frequent testing revealed. However, infected patients did not experience more severe clinical courses or worse clinical outcome. Our observation is in line with published reports indicating that individuals with CF are not at higher risk for severe COVID-19.